Research is being conducted on the relationship between lipoprotein(a) and PCSK9 in the context of premature coronary artery disease. The studies appear to involve various factors, including genetic variants, statin treatment, and liver disease, and may focus on specific populations, such as young females or those with familial hypercholesterolaemia. The exact nature and findings of the research are not clear, but it seems to be exploring the complex interactions between different health conditions and lipid levels.